NCT00211094View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation

PHASE3CompletedINTERVENTIONAL

Enrollment

1,320

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2004

Conditions

Ejaculation

Interventions

DRUG

Dapoxetine

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY

NCT00211094 - A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation | Biotech Hunter | Biotech Hunter